Naftidrofuryl

This MedLibrary.org supplementary page on Naftidrofuryl is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Naftidrofuryl
Systematic (IUPAC) name
2-diethylaminoethyl 2-(naphthalen-1-ylmethyl)-
3-(oxolan-2-yl)propanoate
Identifiers
CAS number 31329-57-4
ATC code C04AX21
PubChem 4417
Chemical data
Formula C24H33NO3 
Mol. mass 383.524 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic.[1] It may also be a 5-HT2 receptor antagonist.

References

  1. ^ Reynolds, J.E.F. (ed.) (1993). Martindale: The extra pharmacopoeia, 30th edition, London: Pharmaceutical Press, p. 1310. ISBN 0853693005. 


Wikipedia content modification information:

  • This page was last modified on 4 July 2007, at 23:12.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Naftidrofuryl".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.